{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:40:07Z","timestamp":1745926807144,"version":"3.40.4"},"reference-count":34,"publisher":"Rambam Health Corporation","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rambam Maimonides Med J"],"abstract":"<jats:p>Background and Aims: Irritable bowel syndrome (IBS) poses a significant healthcare challenge, characterized by chronic gastrointestinal and extraintestinal symptoms impacting individuals\u2019 well-being. Treatment preferences may vary among patients from different ethnic groups, such as Arab and Jewish Israelis, necessitating tailored approaches.\n\nMethods: A bilingual (Hebrew\/Arabic) questionnaire assessing patients\u2019 preferences regarding treatment goals was developed. It was administered online in Israeli IBS Facebook groups, as well as in two hospital gastroenterology clinics.\n\nResults: The study included 267 IBS patients (91 Arabs and 176 Jews). Demographic analysis revealed a higher proportion of females in both groups, with a significantly greater percentage among Jews compared to Arabs (84% versus 64.8%, respectively, P&lt;0.001). The median age was 32 years for both Arabs and Jews (interquartile ranges of 26\u201342 and 24\u201362, respectively). Arabs exhibited higher rates of mixed-type IBS and constipation, while Jews had a higher prevalence of predominant diarrhea IBS. Arabs reported more bloating, higher rates of IBS-related comorbidities, and more medication usage. When asked to rate the importance of treatment goals, both populations preferred improvement in abdominal pain, bloating, and regular defecation, while assigning lower importance to improving difficulty in mental and\/or physical aspects of intercourse, as well as arthralgia and myalgia. Arab patients assigned lower importance scores to various symptoms compared to their Jewish counterparts.\n\nConclusion: This study highlights the impact of ethnicity on patients\u2019 treatment goals. Understanding patients\u2019 preferences will enable tailoring an individual approach to each IBS patient.<\/jats:p>","DOI":"10.5041\/rmmj.10542","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T05:57:06Z","timestamp":1745906226000},"page":"e0007","source":"Crossref","is-referenced-by-count":0,"title":["Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel Syndrome"],"prefix":"10.5041","volume":"16","author":[{"name":"The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vered","family":"Richter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efrat","family":"Broide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Jecheskiel Sigi Gonczarowski Pediatric Gastroenterology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzippora","family":"Shalem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Jecheskiel Sigi Gonczarowski Pediatric Gastroenterology Unit, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel L.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Gonczarowski Family Institute of Gastroenterology and Liver Disease, Shamir (Assaf Harofeh) Medical Center, Zerifin, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawfik","family":"Khoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Gastroenterology and Hepatology Institute, Nazareth Hospital EMMS, Nazareth, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Azrieli Faculty of Medicine, Bar Ilan University, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atallah","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Gastroenterology and Hepatology Institute, Nazareth Hospital EMMS, Nazareth, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timna","family":"Naftali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Department of Gastroenterology, Meir Medical Center, Kfar Saba, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timna","family":"Mari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Gastroenterology and Hepatology Institute, Nazareth Hospital EMMS, Nazareth, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"The Azrieli Faculty of Medicine, Bar Ilan University, Israel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2983","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","unstructured":"1. Mearin F, Lacy BE, Chang L, et al. Bowel disorders. Gastroenterology 2016;150:1393-407.e5.","DOI":"10.1053\/j.gastro.2016.02.031"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1016\/j.cgh.2023.01.017","article-title":"The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs","volume":"21","author":"MHMA","year":"2023","unstructured":"2. Bosman MHMA, Weerts ZZRM, Snijkers JTW, et al. The socioeconomic impact of irritable bowel syndrome: an analysis of direct and indirect health care costs. Clin Gastroenterol Hepatol 2023;21:2660-9.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1111\/apt.16939","article-title":"Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom","volume":"56","author":"Goodoory","year":"2022","unstructured":"3. Goodoory VC, Ng CE, Black CJ, Ford AC. Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom. Aliment Pharmacol Ther 2022;56:110-20.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1007\/BF02071408","article-title":"Impact of irritable bowel syndrome on quality of life","volume":"41","author":"Whitehead","year":"1996","unstructured":"4. Whitehead WE, Burnett CK, Cook EW 3rd, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sci 1996;41:2248-53.","journal-title":"Dig Dis Sci"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Sperber AD, Freud T, Abu-Freha N, et al. Epidemiology of disorders of gut-brain interaction in Israel: results from the Rome Foundation global epidemiology study. Neurogastroenterol Motil 2022;34:e14323.","DOI":"10.1111\/nmo.14323"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"6. Shiha MG, Aziz I. Review article: Physical and psychological comorbidities associated with irritable bowel syndrome. Aliment Pharmacol Ther 2021; 54(Suppl 1):S12-23.","DOI":"10.1111\/apt.16589"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1053\/j.gastro.2005.11.061","article-title":"Functional bowel disorders","volume":"130","author":"Longstreth","year":"2006","unstructured":"7. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130:1480-91.","journal-title":"Gastroenterology"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.5056\/jnm.2010.16.2.113","article-title":"Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes","volume":"16","author":"AD","year":"2010","unstructured":"8. Sperber AD, Dekel R. Irritable bowel syndrome and co-morbid gastrointestinal and extra-gastrointestinal functional syndromes. J Neurogastroenterol Motil 2010;16:113-19.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1111\/apt.15325","article-title":"Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome","volume":"50","author":"Zamani","year":"2019","unstructured":"9. Zamani M, Alizadeh-Tabari S, Zamani V. Systematic review with meta-analysis: the prevalence of anxiety and depression in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2019;50:132-43.","journal-title":"Aliment Pharmacol Ther"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1186\/s12905-023-02272-9","article-title":"A cross-sectional study","volume":"23","author":"Camacho","year":"2023","unstructured":"10. Camacho S, D\u00edaz A, P\u00e9rez P, et al. Sexual dysfunction worsens both the general and specific quality of life of women with irritable bowel syndrome. A cross-sectional study. BMC Womens Health 2023;23:134.","journal-title":"BMC Womens Health"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"11. Sperber AD, Shvartzman P, Friger M, Fich A. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the \"true\" prevalence of irritable bowel syndrome? Eur J Gastroenterol Hepatol 2007;19:441-7.","DOI":"10.1097\/MEG.0b013e32801140e2"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1365-2982.2005.00623.x","article-title":"Unexpectedly low prevalence rates of IBS among adult Israeli Jews","volume":"17","author":"Sperber","year":"2005","unstructured":"12. Sperber AD, Shvartzman P, Friger M, Fich A. Unexpectedly low prevalence rates of IBS among adult Israeli Jews. Neurogastroenterology Motil 2005;17: 207-11.","journal-title":"Neurogastroenterology Motil"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ajg.2012.131","article-title":"Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis","volume":"107","author":"RM","year":"2012","unstructured":"13. Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol 2012;107:991-1000.","journal-title":"Am J Gastroenterol"},{"key":"ref13","unstructured":"14. Evan S. The national significance of Israeli demographics at the outset of a new decade. 2021; July. The Institute for National Security Studies website. Available at: https:\/\/www.inss.org.il\/strategic_assessment\/israeli-demographics\/ (accessed March 22, 2024)."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1007\/s10620-017-4623-x","article-title":"Clinical and phenotypic differences in inflammatory bowel disease among Arab and Jewish children in Israel","volume":"62","author":"Rinawi","year":"2017","unstructured":"15. Rinawi F, Assa A, Bashir H, Peleg S, Shamir R. Clinical and phenotypic differences in inflammatory bowel disease among Arab and Jewish children in Israel. Dig Dis Sci 2017;62:2095-101.","journal-title":"Dig Dis Sci"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/j.1464-5491.2011.03516.x","article-title":"Adult-onset diabetes among Arabs and Jews in Israel: a population-based study","volume":"29","author":"Kalter-Leibovici","year":"2012","unstructured":"16. Kalter-Leibovici O, Chetrit A, Lubin F, et al. Adult-onset diabetes among Arabs and Jews in Israel: a population-based study. Diabet Med 2012;29:748-54.","journal-title":"Diabet Med"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1002\/ijc.26431","article-title":"Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel","volume":"131","author":"Zidan","year":"2012","unstructured":"17. Zidan J, Sikorsky N, Basher W, Sharabi A, Friedman E, Steiner M. Differences in pathological and clinical features of breast cancer in Arab as compared to Jewish women in Northern Israel. Int J Cancer 2012; 131:924-9.","journal-title":"Int J Cancer"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1007\/s00455-022-10549-8","article-title":"Ethnic differences in clinical presentations and esophageal high-resolution manometry findings in patients with achalasia","volume":"38","author":"Cohen","year":"2023","unstructured":"18. Cohen DL, Hijazi B, Omari A, et al. Ethnic differences in clinical presentations and esophageal high-resolution manometry findings in patients with achalasia. Dysphagia 2023;38:1247-53.","journal-title":"Dysphagia"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"370","DOI":"10.5056\/jnm21233","article-title":"Ethnic differences in anorectal manometry findings in patients with fecal incontinence: results from a multiethnic cohort according to the London classification","volume":"29","author":"Cohen","year":"2023","unstructured":"19. Cohen DL, Mari A, Bermont A, Yovel DZ, Richter V, Shirin H. Ethnic differences in anorectal manometry findings in patients with fecal incontinence: results from a multiethnic cohort according to the London classification. J Neurogastroenterol Motil 2023;29: 370-7.","journal-title":"J Neurogastroenterol Motil"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40246-017-0100-z","article-title":"The Israeli National Genetic database: a 10-year experience","volume":"11","author":"Zlotogora","year":"2017","unstructured":"20. Zlotogora J, Patrinos GP. The Israeli National Genetic database: a 10-year experience. Hum Genomics 2017;11:5.","journal-title":"Hum Genomics"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"21. Israel S, Maggio N, Ekstein D, et al. Genetic risk factors for antiepileptic drug-induced hypersensitivity reactions in Israeli populations. Epilepsia 2016;57: e205-9.","DOI":"10.1111\/epi.13498"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s11095-018-2472-8","article-title":"genetic basis of delayed hypersensitivity reactions to drugs in Jewish and Arab populations","volume":"35","author":"Aboukaoud","year":"2018","unstructured":"22. Aboukaoud M, Israel S, Brautbar C, Eyal S. genetic basis of delayed hypersensitivity reactions to drugs in Jewish and Arab populations. Pharm Res 2018;35: 211.","journal-title":"Pharm Res"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/cge.14131","article-title":"Pathogenic variant-based preconception carrier screening in the Israeli Jewish population","volume":"101","author":"Davidov","year":"2022","unstructured":"23. Davidov B, Levon A, Volkov H, et al. Pathogenic variant-based preconception carrier screening in the Israeli Jewish population. Clin Genet 2022;101:517-29.","journal-title":"Clin Genet"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1007\/s11136-017-1703-5","article-title":"Cross-cultural adaptation and measurement properties of generic and cancer-related patient-reported outcome measures (PROMs) for use with cancer patients in Brazil: a systematic review","volume":"27","author":"Albach","year":"2018","unstructured":"24. Albach CA, Wagland R, Hunt KJ. Cross-cultural adaptation and measurement properties of generic and cancer-related patient-reported outcome measures (PROMs) for use with cancer patients in Brazil: a systematic review. Qual Life Res 2018;27:857-70.","journal-title":"Qual Life Res"},{"key":"ref24","unstructured":"25. Verissimo R. Quality of life in inflammatory bowel disease: psychometric evaluation of an IBDQ cross-culturally adapted version. J Gastrointestin Liver Dis 2008;17:439-44. PMID:19104706"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. van Andel EM, Koopmann BDM, Crouwel F, et al. Systematic review of development and content validity of patient-reported outcome measures in inflammatory bowel disease: do we measure what we measure? J Crohns Colitis 2020;14:1299-315.","DOI":"10.1093\/ecco-jcc\/jjaa057"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"12899","DOI":"10.12998\/wjcc.v10.i35.12899","article-title":"Do inflammatory bowel disease patient preferences from treatment outcomes differ by ethnicity and gender? A cross-sectional observational study","volume":"10","author":"Naftali","year":"2022","unstructured":"27. Naftali T, Richter V, Mari A, Khoury T, Shirin H, Broide E. Do inflammatory bowel disease patient preferences from treatment outcomes differ by ethnicity and gender? A cross-sectional observational study. World J Clin Cases 2022;10:12899-908.","journal-title":"World J Clin Cases"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1111\/jgh.16174","article-title":"The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: a multi-center study","volume":"38","author":"Khoo","year":"2023","unstructured":"28. Khoo XH, Chong CW, Talha AM, et al. The impact of diet and ethnicity on gut microbiota variation in irritable bowel syndrome: a multi-center study. J Gastroenterol Hepatol 2023;38:1259-68.","journal-title":"J Gastroenterol Hepatol"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"29. Dar-Odeh N, Abu-Hammad O. Herbal Remedies Use in Arab Societies\u200f. In: Laher I, ed. Handbook of Healthcare in the Arab World. Cham, Switzerland: Springer; 2021:1999-1019.","DOI":"10.1007\/978-3-030-36811-1_197"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/ecam\/neh133","article-title":"Tradition and perspectives of Arab herbal medicine: a review","volume":"2","author":"Saad","year":"2005","unstructured":"30. Saad B, Azaizeh H, Said O. Tradition and perspectives of Arab herbal medicine: a review. Evid Based Complement Alternat Med 2005;2:475-9.","journal-title":"Evid Based Complement Alternat Med"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1053\/j.gastro.2023.08.010","article-title":"Prevalence and burden of illness of Rome IV irritable bowel syndrome in the United States: results from a nationwide cross-sectional study","volume":"165","author":"Almario","year":"2023","unstructured":"31. Almario CV, Sharabi E, Chey WD, Lauzon M, Higgins CS, Spiegel BMR. Prevalence and burden of illness of Rome IV irritable bowel syndrome in the United States: results from a nationwide cross-sectional study. Gastroenterology 2023;165:1475-87.","journal-title":"Gastroenterology"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"32. Silvernale C, Kuo B, Staller K. Racial disparity in healthcare utilization among patients with irritable bowel syndrome: results from a multicenter cohort. Neurogastroenterol Motil 2021;33:e14039.","DOI":"10.1111\/nmo.14039"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"33. Boyd T, Garcia-Fischer I, Silvernale C, Anyane-Yeboa A, Staller K. Differences in provider recommendations for Black\/African American and White patients with irritable bowel syndrome. Neurogastroenterol Motil 2024;36:e14742.","DOI":"10.1111\/nmo.14742"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"34. Sasegbon A, Vasant DH. Understanding racial disparities in the care of patients with irritable bowel syndrome: the need for a unified approach. Neurogastroenterol Motil 2021;33;e14152.","DOI":"10.1111\/nmo.14152"}],"container-title":["Rambam Maimonides Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.rmmj.org.il\/userimages\/1909\/1\/PublishFiles\/2017Article.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T11:17:25Z","timestamp":1745925445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.rmmj.org.il\/issues\/66\/articles\/2017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":34,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,29]]}},"URL":"https:\/\/doi.org\/10.5041\/rmmj.10542","relation":{},"ISSN":["2076-9172"],"issn-type":[{"value":"2076-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]}}}